Cargando…
Palbociclib: A New Option for Front-Line Treatment of Metastatic, Hormone Receptor–Positive, HER2-Negative Breast Cancer
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Harborside Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017548/ https://www.ncbi.nlm.nih.gov/pubmed/27648347 |
| _version_ | 1782452767950897152 |
|---|---|
| author | Bowles, Harmony J. Clarke, Kathryn L. |
| author_facet | Bowles, Harmony J. Clarke, Kathryn L. |
| author_sort | Bowles, Harmony J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5017548 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Harborside Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50175482016-09-19 Palbociclib: A New Option for Front-Line Treatment of Metastatic, Hormone Receptor–Positive, HER2-Negative Breast Cancer Bowles, Harmony J. Clarke, Kathryn L. J Adv Pract Oncol Review Article Harborside Press 2015 2015-11-01 /pmc/articles/PMC5017548/ /pubmed/27648347 Text en Copyright © 2015, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes. |
| spellingShingle | Review Article Bowles, Harmony J. Clarke, Kathryn L. Palbociclib: A New Option for Front-Line Treatment of Metastatic, Hormone Receptor–Positive, HER2-Negative Breast Cancer |
| title | Palbociclib: A New Option for Front-Line Treatment of Metastatic, Hormone Receptor–Positive, HER2-Negative Breast Cancer |
| title_full | Palbociclib: A New Option for Front-Line Treatment of Metastatic, Hormone Receptor–Positive, HER2-Negative Breast Cancer |
| title_fullStr | Palbociclib: A New Option for Front-Line Treatment of Metastatic, Hormone Receptor–Positive, HER2-Negative Breast Cancer |
| title_full_unstemmed | Palbociclib: A New Option for Front-Line Treatment of Metastatic, Hormone Receptor–Positive, HER2-Negative Breast Cancer |
| title_short | Palbociclib: A New Option for Front-Line Treatment of Metastatic, Hormone Receptor–Positive, HER2-Negative Breast Cancer |
| title_sort | palbociclib: a new option for front-line treatment of metastatic, hormone receptor–positive, her2-negative breast cancer |
| topic | Review Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017548/ https://www.ncbi.nlm.nih.gov/pubmed/27648347 |
| work_keys_str_mv | AT bowlesharmonyj palbociclibanewoptionforfrontlinetreatmentofmetastatichormonereceptorpositiveher2negativebreastcancer AT clarkekathrynl palbociclibanewoptionforfrontlinetreatmentofmetastatichormonereceptorpositiveher2negativebreastcancer |